| Product Code: ETC4639813 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Contract Cell and Gene Therapy Manufacturing Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Sweden Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Sweden Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2021 & 2031F |
3.6 Sweden Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Sweden Contract Cell and Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Growth in research and development activities in cell and gene therapy |
4.2.3 Favorable government initiatives and funding support |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy manufacturing |
4.3.2 Regulatory challenges and compliance requirements |
4.3.3 Limited skilled workforce in advanced manufacturing technologies |
5 Sweden Contract Cell and Gene Therapy Manufacturing Market Trends |
6 Sweden Contract Cell and Gene Therapy Manufacturing Market Segmentations |
6.1 Sweden Contract Cell and Gene Therapy Manufacturing Market, By Vector |
6.1.1 Overview and Analysis |
6.1.2 Sweden Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2021-2031F |
6.1.3 Sweden Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2021-2031F |
6.2 Sweden Contract Cell and Gene Therapy Manufacturing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Sweden Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2021-2031F |
6.2.3 Sweden Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2021-2031F |
6.2.4 Sweden Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Herpetological Diseases, 2021-2031F |
6.2.5 Sweden Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021-2031F |
7 Sweden Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Sweden Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Sweden Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries |
8 Sweden Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators |
8.1 Percentage increase in the number of clinical trials utilizing cell and gene therapies in Sweden |
8.2 Average time taken for the approval of new cell and gene therapy products in Sweden |
8.3 Percentage of total research funding allocated to cell and gene therapy manufacturing in Sweden |
9 Sweden Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Sweden Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2021 & 2031F |
9.2 Sweden Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Sweden Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Sweden Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Sweden Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here